Cisplatin Versus Carboplatin for Patients With Metastatic Non–Small-Cell Lung Cancer—An Old Rivalry Renewed

Christopher G. Azzoli Mark G. Kris and David G. Pfister

首页> 外文期刊>Journal of the National Cancer Institute >Cisplatin Versus Carboplatin for Patients With Metastatic Non–Small-Cell Lung Cancer—An Old Rivalry Renewed

【24h】

Cisplatin Versus Carboplatin for Patients With Metastatic Non–Small-Cell Lung Cancer—An Old Rivalry Renewed

机译：顺铂与卡铂治疗转移性非小细胞肺癌患者的比较

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of the National Cancer Institute》 |2007年第11期|828-829|共2页
作者
Christopher G. Azzoli Mark G. Kris and David G. Pfister;
展开▼
作者单位

Affiliation of authors: Department of Medicine Memorial Sloan-Kettering Cancer Center New York NY;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Paclitaxel-etoposide-carboplatin/cisplatin versus etoposide- carboplatin/cisplatin as first-line treatment for combined small-cell lung cancer： a retrospective analysis of 62 cases [J] . Yue-Ya Li, Chan Zhou, Deng-Xia Yang, 癌症生物学与医学：英文版 . 2015,第002期

机译：紫杉醇-依托泊苷-卡铂/顺铂与依托泊苷-卡铂/顺铂一线治疗合并小细胞肺癌：62例回顾性分析
2. Survival and Toxicity After Cisplatin Plus Etoposide Versus Carboplatin Plus Etoposide for Extensive-Stage Small-Cell Lung Cancer in Elderly Patients [J] . Laura A. Hatfield, Haiden A. Huskamp, Elizabeth B. Lamont Journal of Oncology Practice . 2016,第7期

机译：顺铂加依托泊苷与卡铂加依托泊苷对老年大细胞期小细胞肺癌患者的生存和毒性
3. Cisplatin- Versus Carboplatin-Based Chemotherapy in First-Line Treatment of Advanced Non–Small-Cell Lung Cancer: An Individual Patient Data Meta-analysis [J] . Andrea Ardizzoni Luca Boni Marcello Tiseo Frank V. Fossella Joan H. Schiller Marianne Paesmans Davorin Radosavljevic Adriano Paccagnella Petr Zatloukal Paola Mazzanti Donald Bisset and Rafael Rosell For the CISCA (CISplatin versus CArboplatin) Meta-analysis Group Journal of the National Cancer Institute . 2007,第11期

机译：顺铂与卡铂为基础的化学疗法在晚期非小细胞肺癌的一线治疗中：个体患者数据的荟萃分析
4. Molecular Characterization of Circulating Tumor Cells Enriched by a Microfluidic Platform in Patients with Small-Cell Lung Cancer [C] . Robert Zeilinger International Molecular Medicine Tri-Conference. . 2019

机译：小细胞肺癌患者微流体平台富集的循环肿瘤细胞的分子表征
5. Patient Derived Xenograft Models of Small-cell Lung Cancer Provide Molecular Insights into Mechanisms of Chemotherapy Cross-resistance [D] . Myers, David T. 2018

机译：小细胞肺癌的患者衍生异种移植模型为化学疗法交叉耐药机制提供分子见解
6. Paclitaxel-etoposide-carboplatin/cisplatin versus etoposide-carboplatin/cisplatin as first-line treatment for combined small-cell lung cancer: a retrospective analysis of 62 cases [O] . Yue-Ya Li, Chan Zhou, Deng-Xia Yang, 2015

机译：紫杉醇-依托泊苷-卡铂/顺铂与依托泊苷-卡铂/顺铂一线治疗合并小细胞肺癌：62例回顾性分析
7. First-Line Pemetrexed Plus Cisplatin Followed by Gefitinib Maintenance Therapy Versus Gefitinib Monotherapy in East Asian Never-Smoker Patients With Locally Advanced or Metastatic Nonsquamous Non–Small-cell Lung Cancer: Quality of Life Results From a Randomized Phase III Trial [O] . Boye Mark, Wang Xin, Srimuninnimit Vichien, 2016

机译：一线培美曲塞加顺铂再加吉非替尼维持治疗与吉非替尼单药治疗在患有局部晚期或转移性非鳞状非小细胞肺癌的东亚非吸烟患者中的生活质量来自一项随机III期试验

Cisplatin Versus Carboplatin for Patients With Metastatic Non–Small-Cell Lung Cancer—An Old Rivalry Renewed

著录项

相似文献

相关主题

期刊订阅